PrecisionView: A Handheld AI Microscope Redefining Cancer Detection
Researchers at Rice University and MD Anderson Cancer Center have unveiled PrecisionView, a pen-sized handheld endomicroscope that merges deep learning-optimized optics with real-time image reconstruction. The device offers high-resolution, wide-field imaging of tissue, designed to spot cancer with unprecedented clarity and speed.
Key Capabilities
- Size & Design: PrecisionView is a compact, pen-like instrument.
- Improved Vision: Achieves a field of view five times larger and a depth of field eight times greater than conventional systems—while still delivering cellular-level resolution.
- Real-Time Imaging: Visualizes subcellular structures and microvascular patterns simultaneously across tissue areas larger than 1 square centimeter. Results are displayed live at up to 15 frames per second.
- Validation: Tested on healthy volunteers (oral cavity imaging) and human tissue samples with precancerous lesions (cervical tissue).
- Cost: Approximately $3,000.
How It Works
PrecisionView uses a custom-designed phase mask paired with an AI reconstruction algorithm to expand both depth of field and field of view.
AI was used to redesign the optics, breaking the conventional trade-off between depth of field and resolution.
What Experts Say
Rebecca Richards-Kortum (corresponding author): "PrecisionView enables seeing both detail and coverage in real time without trade-offs."
Ashok Veeraraghavan (co-author): "The AI-designed optics improve depth of field, making the device practical for handheld use."
Kathleen Schmeler (co-author): "The device could improve access to early detection in medically underserved areas."
Potential Applications
- Guiding biopsies and surgical decisions.
- Enabling earlier cancer detection during routine screenings.
- Deployment in low-resource settings lacking pathology infrastructure.
Limitations
Larger clinical studies are needed to fully validate diagnostic accuracy.
Funding
Supported by the National Institute of Dental and Craniofacial Research, National Cancer Institute (MD Anderson Cancer Center Support Grant), and the Defense Advanced Research Projects Agency.